The global burden of fatty liver disease:the major impact of China  

作　　者：Tian-Wen Lou Rui-Xu Yang Jian-Gao Fan 

机构地区：[1]Department of Gastroenterology,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai,China [2]The First Clinical Medical College,Anhui Medical University,Hefei,China

出　　处：《Hepatobiliary Surgery and Nutrition》2024年第1期119-123,共5页肝胆外科与营养（英文）

基　　金：supported by the National Natural Science Foundation of China(Nos.82170593,81900507).

摘　　要：Due to the energy-dense but nutrient-deficient diets,sedentary lifestyle and lack of exercise as well as an aging population,the prevalence and incidence of overweight/obesity/sarcopenic obesity,type 2 diabetes mellitus(T2DM),metabolic syndrome and their related non-alcoholic fatty liver disease(NAFLD)have been increasing globally in the last two decades.In Europe and the United States,NAFLD has become the second leading cause of end-stage liver disease and liver transplantation(1).Worse still,the onset age of NAFLD is becoming younger tendency.Although the new nomenclature of metabolic dysfunction-associated fatty liver disease(MAFLD)has been proposed for 3 years,MAFLD is not equivalent to NAFLD,and few epidemiologic investigations on MAFLD to date.Therefore,this invited editorial is focus on the global epidemiology of NAFLD and the major impact on China.

关 键 词：Fatty liver disease(FLD) PREVALENCE OBESITY type 2 diabetes mellitus(T2DM) hepatitis B virus(HBV) 

分 类 号：R575.5[医药卫生—消化系统]